Subhasree Sridhar

机构：CUNY School of Law, Icahn School of Medicine at Mount Sinai · ORCID：0000-0001-8189-9836

发表论文 26 篇 · 总被引 332 次 · h-index 5

代表论文

Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression (2018 · Journal of Clinical Investigation · 被引 176)
Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels (2021 · Science Advances · 被引 91)
MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin looping (2023 · Nature Cell Biology · 被引 28)
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer (2024 · Cell Reports Medicine · 被引 13)
Abstract LB-277: Characterization of the anti-cancer and immunologic activity of RGX-019, a novel pre-clinical stage humanized monoclonal antibody targeting the MERTK receptor (2019 · Cancer Research · 被引 5)
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer (2025 · Cell Reports Medicine · 被引 4)